Anti-inflammatory effects of GLP-1 medicines independent of weight loss Several GLP-1 medicines, including semaglutide, liraglutide, and exenatide, reduce plasma levels of C-reactive protein (CRP), a surrogate of systemic inflammation, in people with obesity or T2D
Each pill contains 60mg of orlistat
Significant weight loss typically takes three to six months of consistent treatment
Activity changes and other triggers reported in the literature, such as strenuous exercise or hernia-related effects, could not be fully assessed from available clinical documentation
Arch Gen Psychiatry 64 : 297304
Although rare, serious side effects may occur including seizures, suicidal thoughts, opiate overdose (if taken WITH opioids), increases in blood pressure, liver toxicity, and angle-closure glaucoma